Real-world evidence for patient phenotypes in heart failure with preserved ejection fraction

Back

ESC Professional Premium Access

Real-world evidence for patient phenotypes in heart failure with preserved ejection fraction

Session: Heart failure therapy: new insights

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor T. Mondritzki (Wuppertal, DE)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Thomas Mondritzki

Bayer AG, Wuppertal (Germany)

0 follower

7 more presentations in this session

Treatment with flozins across the whole spectrum of heart failure in Poland between February 2022 and June 2023 based on Heart Failure Observational Study by Polish Cardiac Society..

Speaker: Doctor R. Morawiec (Lodz, PL)

Feasibility and efficacy of acetazolamide in the treatment of acute decompensated heart failure

Speaker: Doctor Y. Iemura (kuki, JP)

Efficacy of acetazolamide as adjunct therapy in improving fluid management in patients with acute congestive heart failure: a systematic review and meta-analysis of randomized controlled trials

Speaker: Doctor I. Tolentino Narciso (Montes Claros, BR)

The efficacy of IV iron in anemic heart failure patients: a systemic review and meta-analysis of randomised controlled trials.

Speaker: Doctor A. Al Qurm (JO)

Effects of anakinra on patients with heart failure below and above 60 years of age

Speaker: Doctor M. Golino (Richmond, US)

Access the full session

Heart failure therapy: new insights

Speakers: Doctor T. Mondritzki, Doctor R. Morawiec, Doctor Y. Iemura, Doctor I. Tolentino Narciso, Doctor A. Al Qurm...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources